• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN BTK TURBOHAWK; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN BTK TURBOHAWK; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis/Thrombus (4440); Restenosis (4576)
Event Date 01/18/2022
Event Type  Injury  
Manufacturer Narrative
Title: short-term efficacy and safety of turbohawk atherectomy for in-stent restenosis in peripheral artery disease: a single-centre experience author: yi qin, yan shi, huawei zhuo journal: anz journal of surgery year: 2022 vol/issue: 1-5 ref: 10.1111/ans.16551.Date of event: date of publication.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted detailing a study which was performed to investigate the curative efficacy and safety of the turbohawk system for in-stent restenosis in peripheral artery disease (pad) patients over 60 years old.28 patients were included in the study.Surgical procedures were performed using the uncovered turbohawk atherectomy device through a femoral artery puncture (modified seldinger technique) under local anesthesia.The uncovered spider fx embolic protection device was placed below the target lesion to prevent distal embolization.Surgery was terminated when the residual stenosis was 30%.One patient who had a hepatoma and long-term history of anti-tumour therapy developed a thrombus (tibiofibular artery) on the first postoperative day and received thrombolytic and anticoagulant therapy.The patient developed foot ulcers and necrosis on the 55th postoperative day and developed restenosis (minimum diameter reduction = 58.96%) on the 76th postoperative day.On the 76th postoperative day, amputation was performed on the right thigh.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BTK TURBOHAWK
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key13898650
MDR Text Key293177336
Report Number2183870-2022-00101
Device Sequence Number1
Product Code MCW
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K103618
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/25/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/15/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient SexMale
-
-